Re-dosing study of outlier in BA/BE studies [Design Issues]

posted by harrypotter_1234567 – 2010-11-23 13:53 (5699 d 05:13 ago) – Posting: # 6195
Views: 6,936

Hi,
suppose if i conduct two way crossover BA/BE study in 60 subjects, out of this 60 subjects, if 1 subject is considered outlier as per analytical data.
How can we plan redosing study in 10 subjects including anamolus?

If anamolous subject gets the same concentration data as same as previous study, what should be done with study results?

Or is there any provision for outlier in any guideline?

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
246 visitors (0 registered, 246 guests [including 12 identified bots]).
Forum time: 20:06 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5